Ardian has provided a loan to back Telemos Capital and MedEuropa’s acquisition of CCO Perpignan, a French provider of radiotherapy treatments. No financial terms were disclosed.
Paris, January 21st, 2020 – Ardian, a world leading private investment house, today announces the arrangement of a senior financing facility to support Telemos Capital and MedEuropa’s acquisition of CCO Perpignan. The financing package also includes a committed acquisition facility to finance future build-ups.
MedEuropa is a European cancer care company with a strong focus on radiotherapy. Radiotherapy is one of the most commonly used therapies for cancer treatment and consists in the use of high doses of radiation to eliminate cancer cells and shrink tumors. It can be used as a standalone oncology treatment or in combination with other cancer treatments such as surgery or chemotherapy.
Headquartered in Switzerland, the MedEuropa platform was founded in 2017 by Telemos Capital. The network was initially created through the acquisition of two radiotherapy centers in Germany in January 2019 (Krefeld and Hannover, the leading providers of Gamma Knife treatments, a specialized application of radiotherapy for complex brain tumors) and is to be further enlarged through the acquisition of CCO Perpignan, a radiotherapy center in the South of France.
The combination of all three entities will form a Group operating a total of six treatment machines treating a total c. 2,900 patients per year. As has been the case with the German acquisitions, MedEuropa will continue to partner with the CCO Perpignan doctors, ensuring continuity of high-quality care for patients and referring physicians.
Guillaume Chinardet, Head of Ardian Private Debt France, said: “We look forward to the long term cooperation with the MedEuropa management team and Telemos Capital, valuable partners with strong expertise in the European healthcare services market. We are convinced that MedEuropa will achieve further growth via strategic acquisitions in the fragmented European radiotherapy market.”
Jean-David Ponsin, Managing Director at Ardian Private Debt, further added: ”We are pleased to support the Group in this new chapter of its growth journey and we are convinced that our financing solution will provide the Group with the flexibility to pursue its future development.”
Ralph Hefti, MedEuropa’s CEO, commented: “Ardian’s ability to offer a flexible solution to the Group’s requirements was key to this partnership. Ardian has been extremely responsive and creative and has set up financing that is perfectly suited to the way MedEuropa intends to move forward.”
Nils Hagerstål, Vice President at Telemos Capital concluded: ”MedEuropa is actively considering further acquisition opportunities in the radiotherapy market, with the aim of building a platform in Western Europe. This ambitious development strategy demands a solid yet flexible financing solution, which Ardian has successfully provided.”
ABOUT CCO PERPIGNAN
The CCO Perpignan center is located in Perpignan, in the South of France. It focuses on radiotherapy treatments through the operation of linear accelerators, treating a total 1,800 patients. It also provides some chemotherapy treatments in a more limited manner. CCO Perpignan enjoys a strong local reputation in the Pyrenées-Orientales region, and is known for providing high quality treatments to patients.
Founded in 2017, MedEuropa is committed to providing state of the art cancer treatment across Europe, with a strong focus on radiotherapy. MedEuropa seeks to partner with leading medical professionals, who share its vision of improving the provision and quality of cancer treatment. MedEuropa is pursuing an ambitious buy and build strategy, focusing on new partnership and acquisition opportunities across Europe.
Ardian is a world-leading private investment house with assets of US$96bn managed or advised in Europe, the Americas and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base. Through its commitment to shared outcomes for all stakeholders, Ardian’s activities fuel individual, corporate and economic growth around the world. Holding close its core values of excellence, loyalty and entrepreneurship, Ardian maintains a truly global network, with more than 640 employees working from fifteen offices across Europe (Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, Paris and Zurich), the Americas (New York, San Francisco and Santiago) and Asia (Beijing, Singapore, Tokyo and Seoul). It manages funds on behalf of around 1,000 clients through five pillars of investment expertise: Fund of Funds, Direct Funds, Infrastructure, Real Estate and Private Debt.
ABOUT TELEMOS CAPITAL
Telemos Capital invests in private European businesses, with the aim of building great companies for the long term. Funded by family capital, it combines the flexibility and nimble decision-making of a family office with the active ownership and professionalism of private equity. Telemos looks to deploy €50m-€200m of equity per investment and seeks to acquire majority stakes in businesses with the potential for sustainable growth through international expansion, add-on acquisitions or operational improvements.